Article Text

Download PDFPDF

Optimising patient active role with a user-centred eHealth platform (CONCERTO+) in chronic diseases management: a study protocol for a pilot cluster randomised controlled trial
  1. Marie-Pierre Gagnon1,2,
  2. Mame Awa Ndiaye1,
  3. Alain Larouche3,
  4. Guylaine Chabot3,
  5. Christian Chabot4,
  6. Ronald Buyl5,
  7. Jean-Paul Fortin1,6,
  8. Anik Giguère1,6,
  9. Annie Leblanc1,6,
  10. France Légaré1,6,
  11. Aude Motulsky7,
  12. Claude Sicotte7,
  13. Holly O Witteman6,
  14. Eric Kavanagh8,
  15. Frédérick Lépinay8,
  16. Jacynthe Roberge8,
  17. Carole Délétroz9,
  18. Samira Abbasgholizadeh-Rahimi10
  1. 1Centre de Recherche sur les Soins et les Services de Première Ligne de l’Université Laval, Quebec City, QC, Canada
  2. 2Faculty of Nursing Sciences, Université Laval, Quebec City, QC, Canada
  3. 3Groupe Santé Concerto, Montréal, QC, Canada
  4. 4Patient expert, Quebec City, QC, Canada
  5. 5Faculty of Medicine and Pharmacy, VrjeUniversiteit, Brussel, Belgium
  6. 6Department of Family and Emergency Medicine, Université Laval, Quebec City, QC, Canada
  7. 7Department of Health Management, Evaluation and Policy, School of Public Health, Université de Montréal, Montréal, QC, Canada
  8. 8École de design, Université Laval, Quebec City, QC, Canada
  9. 9School of Health Sciences (HESAV), HES-SO University of Applied Sciences and Arts Western Switzerland Lausanne, Lausanne, Switzerland
  10. 10Department of Family Medicine, Mc Gill University, Montréal, QC, Canada
  1. Correspondence to Professor Marie-Pierre Gagnon; marie-pierre.gagnon{at}fsi.ulaval.ca

Abstract

Introduction Multimorbidity increases care needs and primary care use among people with chronic diseases. The Concerto Health Program (CHP) has been developed to optimise chronic disease management in primary care services. However, in its current version, the CHP primarily targets clinicians and does not aim to answer directly patients’ and their informal caregivers’ needs for chronic disease management. Various studies have shown that interventions that increase patient activation level are associated with better health outcomes. Furthermore, educational tools must be adapted to patients and caregivers in terms of health literacy and usability. This project aims to develop, implement and evaluate a user-centred, multifunctional and personalised eHealth platform (CONCERTO+) to promote a more active patient role in chronic disease management and decision-making.

Methods and analysis This project uses a collaborative research approach, aiming at the personalisation of CHP through three phases: (1) the development of one module of an eHealth platform based on scientific evidence and user-centred design; (2) a feasibility study of CONCERTO+ through a pilot cluster randomised controlled trial where patients with chronic diseases from a primary healthcare practice will receive CONCERTO+ during 6 months and be compared to patients from a control practice receiving usual care and (3) an analysis of CONCERTO+ potential for scaling up. To do so, we will conduct two focus groups with patients and informal caregivers and individual interviews with health professionals at the two study sites, as well as health care managers, information officers and representatives of the Ministry of Health.

Ethics and dissemination This study received ethical approval from Ethics Committee of Université Laval. The findings will be used to inform the effectiveness of CONCERTO+ to improve management care in chronic diseases. We will disseminate findings through presentations in scientific conferences and publication in peer-reviewed journals.

Trial registration number NCT03628963; Pre-results.

  • chronic disease management
  • multimorbidity
  • ehealth
  • health literacy
  • user-centered design
  • patient and caregiver engagement

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors M-PG, AL, GC and CC conceived and designed the study and drafted the manuscript. AG, J-PF, FLég, HOW, AL, RB, CS, AM, SA-R, CD, EK, FLép, JR and MAN participated in designing the study and revised the manuscript. All authors read and approved the final manuscript.

  • Funding This study is funded by the Canadian Institutes of Health Research. Funding reference number: PCG-155469.

  • Competing interests None declared.

  • Ethics approval This study has ethical approval from the sectorial committee of research ethics in health science of Université Laval. Approval number: 2018-067/01-06-2018

  • Provenance and peer review Not commissioned; peer reviewed for ethical and funding approval prior to submission.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.